Aurora Cannabis Return on Investment 2017-2019 | ACB

Current and historical return on investment (ROI) values for Aurora Cannabis (ACB) over the last 10 years.
Aurora Cannabis ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-09-30 $-0.21B $3.78B -5.81%
2019-06-30 $-0.24B $3.61B -6.64%
2019-03-31 $-0.25B $3.62B -8.29%
2018-12-31 $-0.22B $3.51B -8.90%
2018-09-30 $-0.17B $3.59B -10.06%
2018-06-30 $-0.08B $1.39B -9.95%
2018-03-31 $-0.03B $1.26B -6.11%
2017-12-31 $-0.01B $0.44B -2.22%
2017-09-30 $0.01B $0.25B 8.66%
2017-06-30 $0.01B $0.21B 24.41%
2017-03-31 $0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.407B $0.215B
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.063B 27.19
Medtronic (MDT) Ireland $149.019B 20.57
Stryker (SYK) United States $77.484B 26.05
Boston Scientific (BSX) United States $59.419B 28.05
Baxter (BAX) United States $41.697B 25.28
EssilorLuxottica Societe Anonyme (ESLOY) France $33.939B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.730B 18.65
Terumo (TRUMY) Japan $27.062B 33.77
Coloplast (CLPBY) Denmark $25.790B 41.17
Lonza Group Ag (LZAGY) Switzerland $24.991B 0.00
ResMed (RMD) United States $21.480B 39.63
Smith & Nephew SNATS (SNN) United Kingdom $18.946B 0.00
Sunny Optical Technology (SNPTF) China $17.912B 0.00
Insulet (PODD) United States $11.183B 532.03
Bio-Rad Laboratories (BIO) United States $10.900B 52.32
Hill-Rom Holdings (HRC) United States $7.158B 21.10
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.631B 12.36
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.124B 41.38
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
Canopy Growth (CGC) Canada $5.338B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
ICU Medical (ICUI) United States $3.781B 24.65
NuVasive (NUVA) United States $3.774B 29.72
Neogen (NEOG) United States $3.369B 56.37
GW Pharmaceuticals (GWPH) United Kingdom $3.199B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.183B 0.00
Quidel (QDEL) United States $2.720B 25.81
Agios Pharmaceuticals (AGIO) United States $2.157B 0.00
National Vision Holdings (EYE) United States $2.155B 48.64
InMode (INMD) Israel $1.785B 0.00
Cardiovascular Systems (CSII) United States $1.578B 0.00
AtriCure (ATRC) United States $1.143B 0.00
VAREX IMAGING (VREX) United States $1.132B 22.68
Aphria (APHA) $1.084B 0.00
Phibro Animal Health (PAHC) United States $0.941B 17.61
NanoString Technologies (NSTG) United States $0.858B 0.00
Lantheus Holdings (LNTH) United States $0.829B 20.72
Eagle Pharmaceuticals (EGRX) United States $0.793B 30.37
TG Therapeutics (TGTX) United States $0.790B 0.00
Omeros (OMER) United States $0.691B 0.00
LeMaitre Vascular (LMAT) United States $0.689B 38.70
PetIQ (PETQ) United States $0.669B 16.32
Quanterix (QTRX) United States $0.649B 0.00
Cerus (CERS) United States $0.606B 0.00
Surmodics (SRDX) United States $0.529B 55.20
OraSure Technologies (OSUR) United States $0.472B 28.33
HEXO (HEXO) $0.468B 0.00
MacroGenics (MGNX) United States $0.424B 0.00
Owens & Minor (OMI) United States $0.400B 14.79
Utah Medical Products (UTMD) United States $0.382B 27.68
Meridian Bioscience (VIVO) United States $0.374B 12.87
Organigram Holdings (OGI) Canada $0.362B 0.00
BioLife Solutions (BLFS) United States $0.310B 126.17
Zynex (ZYXI) United States $0.292B 33.04
Neptune Wellness Solutions (NEPT) Canada $0.254B 0.00
Viemed Healthcare (VMD) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.231B 0.00
Vapotherm (VAPO) United States $0.230B 0.00
United Health Products (UEEC) United States $0.226B 0.00
Repro-Med Systems (KRMD) United States $0.166B 0.00
InfuSystems Holdings (INFU) United States $0.147B 740.00
Cytosorbents (CTSO) United States $0.135B 0.00
Rockwell Medical (RMTI) United States $0.132B 0.00
Fonar (FONR) United States $0.130B 9.18
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Female Health (VERU) United States $0.124B 0.00
Chimerix (CMRX) United States $0.118B 0.00
United-Guardian (UG) United States $0.088B 22.27
Chembio Diagnostics (CEMI) United States $0.075B 0.00
Nephros (NEPH) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
MTech Acquisition (KERN) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.043B 0.00
Surface Oncology (SURF) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00